Hedge fund profile
Sofinnova Bioequities Enhanced Master Fund, LP
Sofinnova Bioequities Enhanced Master Fund, LP is reported as a hedge fund in Form ADV private-fund disclosures. The adviser is Sofinnova Investments, Inc., based in Menlo Park, California, United States.
$1.2Bgross assets
$3.0Mminimum
28owners
3(c)(7)exemption
Disclosure fields
Fund facts
SEC private fund ID805-6350579768
Reference ID337214
JurisdictionDelaware, United States
Fund of fundsNo
Master fundYes
Feeder fundYes
Non-US ownership93%
Assets valued100%
Annual auditYes
GAAPYes
Source periodMarch 2026
Date submitted03/27/2026 02:07:52 PM
Adviser
TypeRegistered investment adviser
SEC number801-110134
CRD160297
Regulatory AUM$5.4B
Compliance signals
Exempt from registration Sales limitation not marked Prime brokers reported Custodians reported
Service providers
Reported counterparties
General partners
Sofinnova Bioequities Gp LLC
Auditors
KPMG, LLP
Prime brokers
JEFFERIES LLCGOLDMAN SACHS & CO. LLCJ.P. MORGAN SECURITIES INC.
Custodians
BNY MELLON TRUST COMPANY (IRELAND) LIMITEDGOLDMAN SACHS INTERNATIONALJ.P. MORGAN SECURITIES LLCJEFFERIES LLCGOLDMAN SACHS & CO. LLCCITCO BANK CANADA
Administrators
CITCO FUND ADMINISTRATION (CAYMAN ISLANDS) LIMITED
Same adviser